Mainz Biomed's (NASDAQ: MYNZ) ColoFuture Study Reveals "Groundbreaking Results": ColoAlert® Raises The Bar For Colorectal Cancer Detection - Mainz Biomed (NASDAQ:MYNZ)
Throughout the world, colorectal cancer has emerged as the third most prevalent form of cancer.